Article Text

Download PDFPDF
Restricting tobacco sales to only pharmacies combined with cessation advice: a modelling study of the future smoking prevalence, health and cost impacts
  1. Frederieke S Petrović-van der Deen1,
  2. Tony Blakely1,2,
  3. Giorgi Kvizhinadze1,
  4. Christine L Cleghorn1,
  5. Linda J Cobiac1,
  6. Nick Wilson1
  1. 1Burden of Disease Epidemiology, Equity and Cost Effectiveness Programme (BODE 3), University of Otago, Wellington, New Zealand
  2. 2Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia
  1. Correspondence to Dr Frederieke S Petrović-van der Deen, Burden of Disease Epidemiology, Equity and Cost Effectiveness Programme (BODE 3), University of Otago, Wellington 6242, New Zealand; frederieke.petrovic-vanderdeen{at}otago.ac.nz

Footnotes

  • Contributors FSP-vdD led the writing, intervention specification, adaptation of the established models, analyses and extraction and interpretation of the results. All authors provided advice during analyses, and contributed towards the interpretation of results and drafting of the paper. All authors approved the final manuscript.

  • Funding FSP-vdD was supported by a University of Otago Doctoral Postgraduate Publishing Bursary. CLC, GK, LJC, TB and NW were supported by the BODE3 Programme, which is studying the effectiveness and cost-effectiveness of various health sector interventions and receives funding support from the Health Research Council of New Zealand (Grant numbers 10/248 and 16/443).

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors FSP-vdD led the writing, intervention specification, adaptation of the established models, analyses and extraction and interpretation of the results. All authors provided advice during analyses, and contributed towards the interpretation of results and drafting of the paper. All authors approved the final manuscript.

  • Funding FSP-vdD was supported by a University of Otago Doctoral Postgraduate Publishing Bursary. CLC, GK, LJC, TB and NW were supported by the BODE3 Programme, which is studying the effectiveness and cost-effectiveness of various health sector interventions and receives funding support from the Health Research Council of New Zealand (Grant numbers 10/248 and 16/443).

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.